Fund moves

Procter & Gamble (PG): Bradley Foster & Sargent Inc reduced its stake -6,140 shares

Bradley Foster & Sargent Inc reduced its stake in Procter & Gamble, per its Q1 2026 13F.

198K
Shares reported · -6,140 vs prior quarter
0.44%
Disclosed portfolio weight
$28.6M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

What stands out in this filing

  • 203,893 shares in Q4 2025, 197,753 now (−3.0% in share count).
  • Reported at $28.6M, 0.44% of the portfolio value in this 13F filing.
  • 104 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  2. Mar 27, 2026CongressDisclosed sale of PG — reported range $15,001 - $50,000
  3. Apr 16, 2026CongressDisclosed sale of PG — reported range $15,001 - $50,000
  4. Apr 24, 2026Company filing · Form 8-K · ResultsReported its results
  5. Apr 27, 2026Congress · 1 personMembers of Congress: 2 purchases
  6. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  7. May 15, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000

What came next

  1. Jun 8, 2026CongressDisclosed sale of PG — reported range $15,001 - $50,000
  2. Jul 29, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 29, 2026, The Procter & Gamble Company (the "Company") announced that Jon R. Moeller, Executive Chairman of the Board, will retire from his position as Executive Chairman and as a member of the Board of Directors (“the Board”), effective July 31, 2026.”
  3. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jul 30, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
  5. Aug 5, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
  6. Aug 11, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  7. Aug 17, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  8. Aug 18, 2026Insider · Their largest sale since 2022Officer sold ~$1.24M of PG shares in the open market
  9. Aug 20, 2026Insider · 11 peopleInsiders: 11 sales (~$4.5M)
  10. Aug 21, 2026InsiderCEO sold ~$491K of PG shares in the open market
  11. Aug 24, 2026InsiderOfficer sold ~$52K of PG shares in the open market
  12. Aug 24, 2026CongressDisclosed sale of PG — reported range $50,001 - $100,000
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Procter & Gamble

For Procter & Gamble, OQRO holds 40 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PG page.

How this filing works

Explore the data

Common questions

What does this filing report about Procter & Gamble (PG) stock?

Bradley Foster & Sargent Inc reduced its stake in Procter & Gamble, per its Q1 2026 13F. Now 198K shares, $28.6M reported value, 0.44% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 15, 2026.

What stands out in this filing?

203,893 shares in Q4 2025, 197,753 now (−3.0% in share count). Reported at $28.6M, 0.44% of the portfolio value in this 13F filing. 104 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Procter & Gamble recently?

For Procter & Gamble, OQRO holds 40 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the PG page.

Does this mean PG stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Procter & Gamble

Everything OQRO holds on this company is on its PG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data